Health Care And Privilege: Why Many Americans Can't Access The Same COVID-19 Treatment As Trump
Regeneron Pharmaceuticals says fewer than 10 people have been given an experimental antibody cocktail it gave President Trump to fight the coronavirus.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org.